FIRMQUARRYResearch workspace

US_FEDERAL process · buyer country US · award

ANALYSIS OF NALOXONE USAGE, SAFETY, AND EFFICACY IN THE EMERGENCY DEPARTMENT AND PREHOSPITAL ENVIRONMENT DURING THE COVID-19 PANDEMIC

Department of Health and Human Services

Procedure CONT_AWD_75F40122C00185_7524_-NONE-_-NONE-CPV 541714Other
Not reported
Data last updated Oct 22, 2026 · Source: USAspending.gov
Buyer identifier
Not reported
Procurement method
Not reported
Tender deadline
Not reported
Contract period
Not reported — Not reported
Native value
Not reported
USD comparison
Not shown — no auditable FX observation
Official source
Open notice ↗

Description

ANALYSIS OF NALOXONE USAGE, SAFETY, AND EFFICACY IN THE EMERGENCY DEPARTMENT AND PREHOSPITAL ENVIRONMENT DURING THE COVID-19 PANDEMIC

Suppliers

Official lifecycle

Process timeline

  1. Award announced

    ANALYSIS OF NALOXONE USAGE, SAFETY, AND EFFICACY IN THE EMERGENCY DEPARTMENT AND PREHOSPITAL ENVIRONMENT DURING THE COVID-19 PANDEMIC

    US · usaspendingSource ↗
  2. Value increased

    ANALYSIS OF NALOXONE USAGE, SAFETY, AND EFFICACY IN THE EMERGENCY DEPARTMENT AND PREHOSPITAL ENVIRONMENT DURING THE COVID-19 PANDEMIC

    US · usaspending$119.2KSource ↗

Auditable model output

Predictive intelligence

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Append-only source history

Source records

RecordDateStagesFetched